Annual Accounts Payable
$25.51 M
+$10.68 M+72.03%
December 31, 2023
Summary
- As of February 7, 2025, ABCL annual accounts payable is $25.51 million, with the most recent change of +$10.68 million (+72.03%) on December 31, 2023.
- During the last 3 years, ABCL annual accounts payable has risen by +$18.19 million (+248.48%).
- ABCL annual accounts payable is now at all-time high.
Performance
ABCL Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$34.80 M
+$8.21 M+30.88%
September 30, 2024
Summary
- As of February 7, 2025, ABCL quarterly accounts payable is $34.80 million, with the most recent change of +$8.21 million (+30.88%) on September 30, 2024.
- Over the past year, ABCL quarterly accounts payable has increased by +$8.21 million (+30.88%).
- ABCL quarterly accounts payable is now at all-time high.
Performance
ABCL Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
ABCL Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +72.0% | +30.9% |
| 3 y3 years | +248.5% | +290.6% |
| 5 y5 years | +1580.2% | +2016.5% |
ABCL Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +72.0% | at high | +273.4% |
| 5 y | 5-year | at high | +1451.6% | at high | +2016.5% |
| alltime | all time | at high | +1580.2% | at high | +2016.5% |
AbCellera Biologics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $34.80 M(+30.9%) |
| Jun 2024 | - | $26.59 M(-1.2%) |
| Mar 2024 | - | $26.91 M(+5.5%) |
| Dec 2023 | $25.51 M(+72.0%) | $25.51 M(+46.3%) |
| Sep 2023 | - | $17.43 M(-17.1%) |
| Jun 2023 | - | $21.02 M(+19.7%) |
| Mar 2023 | - | $17.57 M(+18.5%) |
| Dec 2022 | $14.83 M | $14.83 M(+59.1%) |
| Sep 2022 | - | $9.32 M(-9.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $10.31 M(-0.4%) |
| Mar 2022 | - | $10.35 M(-30.6%) |
| Dec 2021 | $14.92 M(+103.9%) | $14.92 M(+67.5%) |
| Sep 2021 | - | $8.91 M(+58.9%) |
| Jun 2021 | - | $5.61 M(+56.3%) |
| Mar 2021 | - | $3.58 M(-51.0%) |
| Dec 2020 | $7.32 M(+345.3%) | $7.32 M(+345.3%) |
| Dec 2019 | $1.64 M(+8.3%) | $1.64 M |
| Dec 2018 | $1.52 M | - |
FAQ
- What is AbCellera Biologics annual accounts payable?
- What is the all time high annual accounts payable for AbCellera Biologics?
- What is AbCellera Biologics annual accounts payable year-on-year change?
- What is AbCellera Biologics quarterly accounts payable?
- What is the all time high quarterly accounts payable for AbCellera Biologics?
- What is AbCellera Biologics quarterly accounts payable year-on-year change?
What is AbCellera Biologics annual accounts payable?
The current annual accounts payable of ABCL is $25.51 M
What is the all time high annual accounts payable for AbCellera Biologics?
AbCellera Biologics all-time high annual accounts payable is $25.51 M
What is AbCellera Biologics annual accounts payable year-on-year change?
Over the past year, ABCL annual accounts payable has changed by +$10.68 M (+72.03%)
What is AbCellera Biologics quarterly accounts payable?
The current quarterly accounts payable of ABCL is $34.80 M
What is the all time high quarterly accounts payable for AbCellera Biologics?
AbCellera Biologics all-time high quarterly accounts payable is $34.80 M
What is AbCellera Biologics quarterly accounts payable year-on-year change?
Over the past year, ABCL quarterly accounts payable has changed by +$8.21 M (+30.88%)